INM InMed Pharmaceuticals Inc. - Common Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Sep 9, 2026
$1.33
· of 52w range
· above low
· to high
$0.5852w low
$2.5052w high
Market Cap (MRQ)
$7M
P/E
-0.4
EPS
$-3.12
Revenue
$5M
your badges
52W Range
$1–$2
Analyst Rating
SELL
Price Target
·
P/E
-0.4
ROE
-235.6%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
INM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.33
Market Cap (MRQ)
$7M
P/E
-0.4
EPS
$-3.12
Revenue
$5M
ROE
-235.6%
52W Range
$1–$3
INM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Nov. 14, 2024 | 1-for-20 | Reverse |
| Sept. 7, 2022 | 1-for-25 | Reverse |
| July 6, 2020 | 1-for-33 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$5M2022-06-30 → 2025-06-30
EPS$-3.122021-06-30 → 2026-06-30
Free Cash Flow·2021-06-30 → 2024-06-30
Net margin·2024-06-30 → 2024-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | INM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.45Y avg ≈-2.8 | ≈-2.8 | · | · | |
| P/S | 1.6 | · | · | · | |
| P/B (MRQ) | 6.6 | · | · | · | |
| Price / Cash Flow | -0.8 | · | · | · | |
| Price / Tangible Book | 6.65Y avg ≈8.5 | ≈8.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | INM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -135.0% | · | · | · | |
| ROE | -235.6% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | INM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.4 | · | · | · | |
| Quick Ratio | 1.1 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | INM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 7.5%5Y avg ≈99.4% | ≈99.4% | · | · | |
| Revenue CAGR 3Y | 65.5% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | INM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$823.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-152.6%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2025 | $-1.94 | — | — | |
| June 30, 2024 | $-0.19 | — | — | |
| March 31, 2024 | $-0.76 | — | — | |
| June 30, 2022 | $-280.60 | $-111.10 | -152.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | · | $5M | $5M | $4M | $1M | |
| Cost of Revenue | · | $3M | $3M | $3M | $545.9K | |
| Gross Profit | · | $2M | $1M | $1M | $543.5K | |
| R&D Expense | $3M | $3M | $3M | $4M | $7M | |
| SG&A Expense | $7M | $5M | $6M | $6M | $7M | |
| Operating Expenses | $12M | $8M | $9M | $10M | $18M | |
| Operating Income | · | · | · | $-8M | $-19M | |
| Interest Income | $245.0K | $155.9K | $527.9K | $492.4K | $96.1K | |
| Other Non-op | · | · | $527.9K | $492.4K | $-1M | |
| Pretax Income | $-11M | $-9M | $-8M | $-8M | $-19M | |
| Income Tax | · | · | $7.1K | $13.1K | · | |
| Net Income | $-13M | $-8M | $-8M | $-8M | $-19M | |
| EPS (Basic) | $-3.12 | $-8.36 | $-20.14 | $-3.25 | $-33.17 | |
| EPS (Diluted) | $-3.12 | $-8.36 | $-20.14 | $-3.25 | $-33.17 | |
| Shares (Basic) | 4,163,598 | 975,895 | 381,053 | 2,448,458 | 560,829 | |
| Shares (Diluted) | 4,163,598 | 975,895 | 381,053 | 2,448,458 | 560,829 | |
| EBITDA | $205.3K | · | $219.6K | · | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $11M | $7M | $9M | $6M | |
| Short-term Investments | $39.7K | $43.4K | $43.1K | $44.4K | $44.8K | |
| Receivables | · | $465.1K | $352.8K | $260.4K | $88.0K | |
| Inventory | · | $961.2K | $1M | $2M | $2M | |
| Prepaid Expense | $241.3K | $319.5K | $477.7K | $498.0K | $797.2K | |
| Current Assets | $3M | $13M | $9M | $11M | $10M | |
| PP&E (Net) | $221.0K | $992.2K | $1M | $723.4K | $904.3K | |
| PP&E (Gross) | $810.7K | $2M | $3M | $2M | $1M | |
| Accum. Depreciation | $373.3K | $1M | $1M | $925.3K | $516.5K | |
| Intangibles | · | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $132.3K | $100.0K | $100.0K | $104.9K | $176.6K | |
| Total Assets | $3M | $16M | $12M | $14M | $13M | |
| Accounts Payable | $2M | $1M | $2M | · | $2M | |
| Accrued Liabilities | · | · | $256.5K | $357.7K | · | |
| Current Liabilities | $2M | $2M | $2M | $2M | $3M | |
| Capital Leases | · | $305.8K | $644.9K | $16.0K | $389.5K | |
| Total Liabilities | $2M | $2M | $3M | $2M | $4M | |
| Common Stock | $94M | $91M | $83M | $78M | $71M | |
| Paid-in Capital | · | · | · | $36M | $32M | |
| Retained Earnings | $-130M | $-117M | $-109M | $-101M | $-93M | |
| AOCI | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | |
| Stockholders' Equity | $1M | $13M | $9M | $12M | $9M | |
| Liabilities + Equity | $3M | $16M | $12M | $14M | $13M | |
| Shares Outstanding | 5,339,436 | 2,002,186 | 445,908 | 166,370 | 650,667 |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| D&A | $205.3K | $212.8K | $219.6K | $202.2K | $185.7K | |
| Stock-based Comp | $106.9K | $119.3K | $137.7K | $278.2K | $697.9K | |
| Amort. of Intangibles | $162.6K | $162.6K | $171.9K | $159.2K | $159.2K | |
| Other Non-cash | $4M | · | $332.4K | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-7M | $-7M | $-16M | |
| CapEx | · | · | $9.3K | $160.0K | $39.1K | |
| Investing Cash Flow | · | · | $-9.3K | $-661.8K | $-673.0K | |
| Stock Issued | · | · | · | $12M | $17M | |
| Financing Cash Flow | $94.5K | $12M | $5M | $11M | $15M | |
| Net Change in Cash | · | · | $-2M | $3M | $-1M | |
| Free Cash Flow | · | · | $-7M | · | · |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Gross Margin | · | · | 23.9% | · | · | |
| Net Margin | · | · | -166.9% | · | · | |
| Pretax Margin | · | · | -166.8% | · | · | |
| EBITDA Margin | · | · | 4.8% | · | · | |
| ROA | -135.0% | · | -59.2% | · | · | |
| ROE | -235.6% | · | -75.6% | · | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | · | 4.4 | · | · | |
| Quick Ratio | 1.1 | · | 3.5 | · | · |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.4 | · | · | |
| Inventory Turnover | · | · | 2.4 | · | · | |
| Receivables Turnover | · | · | 15.0 | · | · |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Book Value / Share | $0.20 | · | $1.03 | · | · | |
| Revenue / Share | · | · | $0.60 | · | · | |
| Cash Flow / Share | $-2.08 | · | $-0.92 | · | · | |
| Cash / Share | $0.41 | · | $0.74 | · | · | |
| EPS (TTM) | $-3.12 | $-8.36 | $-20.14 | $-3.25 | $-33.17 |
Growth Rates
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | 7.5% | 11.2% | 279.6% | · | |
| Revenue CAGR 3Y | · | 65.5% | · | · | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | $5M | $4M | $1M | |
| Net Income TTM | $-13M | $-8M | $-8M | $-8M | $-19M | |
| Market Cap | $8M | · | $47M | · | · | |
| P/E | -0.5 | -0.4 | -0.3 | -5.7 | -7.1 | |
| P/S | 1.8 | · | 10.3 | · | · | |
| P/B | 7.7 | · | 5.2 | · | · | |
| P / Tangible Book | 7.7 | 0.6 | 6.4 | 6.1 | 21.9 | |
| P / Cash Flow | -1.0 | · | -6.8 | · | · | |
| P / FCF | · | · | -6.8 | · | · | |
| Earnings Yield | -201.3% | -257.2% | -378.6% | -17.5% | -14.1% |
Income Statement
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $820.2K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $901.9K | $2M | $1M | $469.8K | $320.8K | |
| Cost of Revenue | · | · | $636.0K | $717.0K | $728.1K | $1M | $650.8K | $771.2K | $817.0K | $883.1K | $916.1K | $880.6K | $1M | $841.4K | $338.6K | $235.0K | |
| Gross Profit | · | · | $184.2K | $403.2K | $576.7K | $175.6K | $460.9K | $493.4K | $466.1K | $289.5K | $324.1K | $21.2K | $2M | $192.5K | $131.2K | $-491.0K | |
| R&D Expense | $793.6K | $1M | $630.6K | $581.6K | $800.5K | $425.4K | $895.2K | $700.1K | $658.9K | $656.8K | $609.8K | $1M | $623.7K | $878.3K | $851.4K | $1M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $618.4K | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | |
| Operating Expenses | $4M | $3M | $2M | $2M | $1M | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | |
| Operating Income | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | $-2M | $-2M | $-4M | |
| Interest Income | $29.1K | $47.8K | $74.4K | $93.8K | $51.7K | $16.6K | $30.5K | $57.1K | $103.6K | $121.5K | $166.8K | $136.0K | $148.6K | $155.5K | $115.8K | $72.6K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | $136.0K | · | · | · | $65.8K | |
| Pretax Income | $-5M | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-336.6K | $-2M | $-2M | $-4M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.8K | |
| Net Income | $-6M | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-338.4K | $-2M | $-2M | $-4M | |
| EPS (Basic) | $-1.44 | $-0.73 | $-0.51 | $-0.44 | $-0.07 | $-1.94 | $-3.64 | $-2.71 | $2.39 | $-3.58 | $-3.71 | $-15.24 | $2.32 | $-0.60 | $-0.91 | $-4.06 | |
| EPS (Diluted) | $-1.44 | $-0.73 | $-0.51 | $-0.44 | $-0.07 | $-1.94 | $-3.64 | $-2.71 | $2.39 | $-3.58 | $-3.71 | $-15.24 | $2.32 | $-0.60 | $-0.91 | $-4.06 | |
| Shares (Basic) | · | 4,048,209 | 3,954,549 | 3,954,549 | · | 1,095,973 | 706,546 | 620,127 | · | 480,649 | 398,673 | 166,410 | · | 3,328,191 | 2,300,526 | 865,619 | |
| Shares (Diluted) | · | 4,048,209 | 3,954,549 | 3,954,549 | · | 1,095,973 | 706,546 | 620,127 | · | 480,649 | 398,673 | 166,410 | · | 3,328,191 | 2,300,526 | 865,619 | |
| EBITDA | · | · | · | $53.2K | · | · | · | $54.6K | · | · | · | $-2M | · | $-2M | $-2M | $-3M |
Balance Sheet
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $7M | $9M | $11M | $5M | $3M | $6M | $7M | $8M | $10M | $7M | $9M | $10M | $11M | $9M | |
| Short-term Investments | $39.7K | $41.6K | $42.7K | $42.9K | $43.4K | $40.6K | $40.8K | $43.2K | $43.1K | $43.1K | $44.5K | $42.9K | $44.4K | $43.1K | $43.1K | $42.1K | |
| Receivables | · | · | $183.0K | $343.5K | $465.1K | $367.8K | $262.6K | $284.7K | $352.8K | $207.7K | $372.9K | $165.8K | $260.4K | $170.3K | $81.6K | $15.2K | |
| Inventory | · | · | $947.9K | $890.8K | $961.2K | $814.0K | $1M | $1M | $1M | $1M | $744.8K | $1M | $2M | $1M | $2M | $2M | |
| Prepaid Expense | $241.3K | $617.2K | $660.3K | $191.8K | $319.5K | $507.9K | $644.0K | $148.9K | $477.7K | $1M | $1M | $215.0K | $498.0K | $695.2K | $826.9K | $356.7K | |
| Current Assets | $3M | $7M | $9M | $11M | $13M | $6M | $5M | $7M | $9M | $10M | $12M | $8M | $11M | $12M | $14M | $12M | |
| PP&E (Net) | $221.0K | $642.9K | $764.3K | $881.5K | $992.2K | $1M | $1M | $1M | $1M | $1M | $1M | $615.1K | $723.4K | $753.2K | $703.9K | $802.4K | |
| PP&E (Gross) | $810.7K | · | · | · | $2M | $2M | $2M | $2M | $3M | $3M | · | $2M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | $373.3K | · | · | · | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $925.3K | $819.3K | $716.8K | $618.4K | |
| Intangibles | · | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $132.3K | $104.4K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $101.8K | $104.9K | $147.5K | $171.1K | $171.1K | |
| Total Assets | $3M | $9M | $11M | $13M | $16M | $9M | $9M | $10M | $12M | $13M | $15M | $11M | $14M | $15M | $17M | $15M | |
| Accounts Payable | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2.0K | $2M | $1M | $1M | $1M | · | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | · | · | $85.5K | · | $167.5K | $100.4K | · | $357.7K | · | · | · | |
| Current Liabilities | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $3M | |
| Capital Leases | · | $30.8K | $123.8K | $215.5K | $305.8K | $419.3K | $529.2K | $633.8K | $644.9K | $725.2K | $802.8K | · | $16.0K | $72.8K | $183.9K | $294.3K | |
| Total Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $1M | $2M | $2M | $3M | $4M | |
| Common Stock | $94M | $93M | $92M | $92M | $91M | $87M | $85M | $84M | $83M | $81M | $80M | $78M | $78M | $78M | $75M | $73M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | $38M | · | · | $36M | $38M | $35M | |
| Retained Earnings | $-130M | $-124M | $-121M | $-119M | $-117M | $-115M | $-113M | $-111M | $-109M | $-107M | $-105M | $-104M | $-101M | $-101M | $-99M | $-97M | |
| AOCI | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | |
| Stockholders' Equity | $1M | $7M | $10M | $12M | $13M | $7M | $6M | $8M | $9M | $11M | $13M | $10M | $12M | $12M | $14M | $11M | |
| Liabilities + Equity | $3M | $9M | $11M | $13M | $16M | $9M | $9M | $10M | $12M | $13M | $15M | $11M | $14M | $15M | $17M | $15M | |
| Shares Outstanding | 5,339,436 | 3,314,063 | 2,804,186 | 2,604,186 | 2,002,186 | 1,207,186 | 724,152 | 667,013 | 445,908 | 6,344,970 | 5,667,970 | 3,328,191 | 3,328,191 | 3,328,191 | 1,589,992 | 908,766 |
Cash Flow
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $48.4K | $50.5K | $53.2K | $53.2K | $52.8K | $52.3K | $53.2K | $54.6K | $54.8K | $54.8K | $55.2K | $54.8K | $53.5K | $50.7K | $49.0K | $49.0K | |
| Stock-based Comp | $22.6K | $38.8K | $25.3K | $20.2K | $26.7K | $40.5K | $23.2K | $29.0K | $39.0K | $55.3K | $18.3K | $25.2K | $40.5K | $50.4K | $70.6K | $116.7K | |
| Amort. of Intangibles | $39.6K | $41.0K | $41.0K | $41.0K | $39.6K | $41.0K | $41.0K | $41.0K | $48.9K | $41.0K | $41.0K | $41.0K | $37.1K | $40.1K | $41.0K | $41.0K | |
| Other Non-cash | · | · | · | $45.9K | · | · | · | $-232.5K | · | · | · | $282.6K | · | · | · | $1M | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-1M | $-2M | $-2M | $-2M | $-657.9K | $-2M | $-3M | $-2M | |
| CapEx | · | · | · | · | · | · | · | · | $0 | $2 | · | · | $31.8K | · | · | · | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | $0 | $-2 | · | · | $-33.6K | $-128.2K | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $174 | $6M | $6M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Financing Cash Flow | $-1 | $231.7K | $0 | $-137.2K | $8M | $3M | $338.5K | $838.2K | $176 | $0 | · | · | $0 | $-63.7K | $5M | $5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | $-2M | · | · | $-691.5K | $-2M | $2M | $3M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.8K |
Profitability
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 22.5% | 36.0% | · | 13.9% | 41.5% | 39.0% | · | 24.7% | 26.1% | 2.4% | · | 18.6% | 27.9% | -153.1% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -281.3% | · | -193.2% | -447.2% | -1094.2% | |
| Net Margin | · | · | -247.3% | -154.2% | · | -168.1% | -231.6% | -132.7% | · | -146.9% | -119.2% | -281.3% | · | -193.2% | -447.2% | -1094.2% | |
| Pretax Margin | · | · | -247.3% | -154.2% | · | -168.1% | -231.6% | -132.7% | · | -146.9% | -119.2% | -281.3% | · | -193.1% | -446.6% | -1092.1% | |
| EBITDA Margin | · | · | · | 4.8% | · | · | · | 4.3% | · | · | · | -275.2% | · | -193.2% | -447.2% | -1079.0% | |
| ROA | · | -32.2% | -20.6% | -14.5% | · | -18.7% | -21.7% | -15.7% | · | -12.3% | -9.2% | -19.9% | · | -13.2% | -11.6% | -22.0% | |
| ROE | · | -42.6% | -25.7% | -17.3% | · | -23.4% | -27.2% | -18.7% | · | -14.7% | -10.9% | -24.6% | · | -17.2% | -14.7% | -26.8% |
Liquidity & Solvency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 3.1 | 5.9 | 6.9 | · | 3.5 | 3.1 | 5.1 | · | 6.6 | 7.0 | 6.2 | · | 5.2 | 5.8 | 3.5 | |
| Quick Ratio | · | 2.4 | 4.9 | 6.2 | · | 2.8 | 2.1 | 4.1 | · | 5.1 | 5.9 | 5.2 | · | 4.3 | 4.8 | 2.9 |
Efficiency
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | 0.6 | 0.7 | · | 1.1 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.5 | · | 0.6 | 0.3 | 0.3 | |
| Receivables Turnover | · | · | 3.7 | 3.6 | · | 4.4 | 3.5 | 5.6 | · | 6.2 | 5.5 | 10.0 | · | 8.6 | 7.1 | 21.4 |
Per Share
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.08 | $3.42 | $4.45 | · | $5.82 | $8.54 | $12.59 | · | $1.75 | $2.25 | $2.88 | · | $3.72 | $9.02 | $12.11 | |
| Revenue / Share | · | · | $0.21 | $0.28 | · | $1.15 | $1.57 | $2.04 | · | $0.12 | $0.16 | $0.27 | · | $0.31 | $0.20 | $0.37 | |
| Cash Flow / Share | · | · | · | $-0.41 | · | · | · | $-2.95 | · | · | · | $-0.65 | · | · | · | $-2.61 | |
| Cash / Share | · | $1.56 | $2.48 | $3.58 | · | $3.88 | $4.72 | $8.37 | · | $1.20 | $1.68 | $2.02 | · | $2.89 | $7.20 | $10.29 | |
| EPS (TTM) | · | $-1.75 | $-2.96 | $-6.09 | · | $-5.90 | $-7.54 | $-7.61 | · | $-20.21 | $-17.23 | $-14.43 | · | $-18.70 | $-24.24 | $-31.06 |
Valuation (TTM)
| Metric | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $6M | $5M | $5M | · | $2M | $2M | $1M | |
| Net Income TTM | · | $-9M | $-8M | $-8M | · | $-8M | $-8M | $-7M | · | $-6M | $-6M | $-7M | · | $-15M | $-17M | $-19M | |
| Market Cap | · | $2M | $3M | $6M | · | $2M | $3M | $3M | · | $46M | $47M | $47M | · | $72M | $64M | $120M | |
| P/E | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.6 | -0.6 | · | -0.4 | -0.5 | -1.0 | · | -1.2 | -1.7 | -4.2 | |
| P/S | · | 0.5 | 0.7 | 1.2 | · | 0.5 | 0.7 | 0.6 | · | 8.2 | 8.6 | 9.9 | · | 30.7 | 39.8 | 85.0 | |
| P/B | · | 0.3 | 0.3 | 0.5 | · | 0.4 | 0.6 | 0.4 | · | 4.2 | 3.7 | 4.9 | · | 5.8 | 4.5 | 10.9 | |
| P / Tangible Book | · | 0.4 | 0.4 | 0.6 | · | 0.5 | 0.8 | 0.5 | · | 5.0 | 4.3 | 6.1 | · | 6.9 | 5.2 | 13.4 | |
| P / Cash Flow | · | · | · | -3.5 | · | · | · | -1.7 | · | · | · | -21.4 | · | · | · | -53.1 | |
| Earnings Yield | · | -271.3% | -279.2% | -278.1% | · | -285.0% | -159.1% | -160.5% | · | -277.6% | -207.1% | -103.1% | · | -86.6% | -60.0% | -23.5% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Revenue | · | $5M | $5M | $4M | $1M |
| Gross Margin % | · | · | 23.9% | · | · |
| Net Income | $-13M | $-8M | $-8M | $-8M | $-19M |
| Diluted EPS | $-3.12 | $-8.36 | $-20.14 | $-3.25 | $-33.17 |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Current Ratio | 1.4 | · | 4.4 | · | · |
| Quick Ratio | 1.1 | · | 3.5 | · | · |
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | $-7M | · | · |
Institutional owners (13F) 21 filers · $4.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
21
Value held
$4.2M
New positions
13
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 13 (+9 vs prior Q) | 2 (0 vs prior Q) | 0 (-2 vs prior Q) | 3 (+3 vs prior Q) | +2.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | $1,240,000 | 800,000 | 29.65% | Shares |
| Vivo Capital, LLC | $1,237,484 | 798,377 | 29.59% | Shares |
| Squadron Capital Management LLC | $503,750 | 325,000 | 12.04% | Shares |
| Ikarian Capital, LLC | $379,788 | 245,025 | 9.08% | Shares |
| Ursa Fund Management, LLC | $194,990 | 125,800 | 4.66% | Shares |
| MONTANOVA CAPITAL, LLC | $155,000 | 100,000 | 3.71% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $115,078 | 74,244 | 2.75% | Shares |
| SABBY MANAGEMENT, LLC | $69,704 | 44,970 | 1.67% | Shares |
| JANE STREET GROUP, LLC | $66,771 | 43,078 | 1.60% | Shares |
| Venrock Adviser, LLC | $50,662 | 32,685 | 1.21% | Shares |
| CITADEL ADVISORS LLC | $40,430 | 26,084 | 0.97% | Shares |
| SEVEN GRAND MANAGERS, LLC | $38,750 | 25,000 | 0.93% | Shares |
| Scientech Research LLC | $23,965 | 15,461 | 0.57% | Shares |
| Crestwood Advisors Group, LLC | $23,095 | 14,900 | 0.55% | Shares |
| TWO SIGMA SECURITIES, LLC | $16,965 | 10,945 | 0.41% | Shares |
| Stratos Wealth Partners, LTD. | $16,678 | 10,760 | 0.40% | Shares |
| Private Wealth Management Group, LLC | $7,750 | 5,000 | 0.19% | Shares |
| Banque Cantonale Vaudoise | $1,000 | 6 | 0.02% | Shares |
| SBI Securities Co., Ltd. | $465 | 300 | 0.01% | Shares |
| Federation des caisses Desjardins du Quebec | $4 | 2 | 0.00% | Shares |
| AllSquare Wealth Management LLC | $2 | 1 | 0.00% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity, LLC, Vivo Opportunity Cayman Fund, L.P., Vivo Opportunity Cayman, LLC | June 10, 2026 | 21.70% | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 18 insiders · 8 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Eric A Adams | President & CEO | Dec. 19, 2025 A | 43,959 | 0 | 0 | $0 |
| Netta Jagpal | Chief Financial Officer | Dec. 19, 2025 A | · | 0 | 0 | $0 |
| Jonathan Tegge | Interim CFO | Dec. 23, 2023 A | · | 0 | 0 | $0 |
| Bruce Colwill | CFO | Jan. 24, 2022 P | 11,515 | 0 | 0 | $0 |
| Michael Woudenberg | Chief Operating Officer | Dec. 19, 2025 A | · | 0 | 0 | $0 |
| Shane Aaron Johnson | Sr VP & General Manager | Dec. 19, 2025 A | 304,595 | 0 | 0 | $0 |
| Eric C Hsu | Sr. VP, Pre-Clinical Res/Dev | Dec. 19, 2025 A | · | 0 | 0 | $0 |
| Sarah Li | VP Accounting & Controller | Dec. 16, 2022 A | · | 0 | 0 | $0 |
| John Steven Bathery | Director | Dec. 19, 2025 A | · | 0 | 0 | $0 |
| Nicole Lemerond | Director | Dec. 19, 2025 A | · | 0 | 0 | $0 |
| Andrew Hull | Director | Dec. 19, 2025 A | 38,258 | 0 | 0 | $0 |
| Neil A Klompas | Director | Dec. 19, 2025 A | · | 0 | 0 | $0 |
| Bryan T Baldasare | Director | Dec. 20, 2024 A | · | 0 | 0 | $0 |
| Janet P Grove | Director | Dec. 20, 2024 A | · | 0 | 0 | $0 |
| Adam D. Cutler | Director | Jan. 24, 2022 H | · | 0 | 0 | $0 |
| William J Garner | Director | Jan. 24, 2022 H | · | 0 | 0 | $0 |
| Catherine Sazdanoff | Director | Dec. 29, 2021 A | · | 0 | 0 | $0 |
| Alexandra Diane Janet Mancini | · | July 31, 2024 S | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
INM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
SELL
0 0.0%
Strong Buy
0 0.0%
Buy
3 37.5%
Hold
4 50.0%
Sell
1 12.5%
Strong Sell
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| INM | $8M | -0.5 | 7.5% | · | -235.6% | · |
| LEXX | $17M | -1.3 | 52.0% | -1686.0% | -215.9% | 99.6% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-K filed Sep 9, 2026